Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study.
about
Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study.Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response.Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumoursEffectiveness of incorporating cetuximab into docetaxel/cisplatin/fluorouracil induction chemotherapy and chemoradiotherapy for inoperable squamous cell carcinoma of the oral cavity: A phase II study.Understanding the Interactions of High-Mobility Group of Protein Domain B1 with DNA Adducts Generated by Platinum Anticancer Molecules Using In Silico Approaches.
P2860
Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Triweekly reduced-dose docetax ...... a multicenter phase II study.
@en
Triweekly reduced-dose docetax ...... a multicenter phase II study.
@nl
type
label
Triweekly reduced-dose docetax ...... a multicenter phase II study.
@en
Triweekly reduced-dose docetax ...... a multicenter phase II study.
@nl
prefLabel
Triweekly reduced-dose docetax ...... a multicenter phase II study.
@en
Triweekly reduced-dose docetax ...... a multicenter phase II study.
@nl
P2093
P2860
P1476
Triweekly reduced-dose docetax ...... : a multicenter phase II study
@en
P2093
Chao-Jung Tsao
Cheng-Hwai Tzeng
Ming-Huang Chen
Muh-Hwa Yang
Peter Mu-Hsin Chang
Shyue-Yih Chang
Wei-Shuo Hwang
Yi-Fang Chang
P2860
P2888
P304
P356
10.1007/S00280-011-1645-5
P50
P577
2011-04-12T00:00:00Z
P6179
1053295873